Summit Therapeutics Inc.SMMTNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+117.9%
5Y CAGR+58.8%
Year-over-Year Change
Research and development spending
3Y CAGR
+117.9%/yr
vs +0.3%/yr prior
5Y CAGR
+58.8%/yr
Recent acceleration
Acceleration
+117.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.1x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $537.67M | +256.6% |
| 2024 | $150.78M | +153.5% |
| 2023 | $59.47M | +14.4% |
| 2022 | $52.00M | -39.1% |
| 2021 | $85.35M | +60.2% |
| 2020 | $53.27M | +36.0% |
| 2019 | $39.18M | -23.7% |
| 2018 | $51.38M | +25.3% |
| 2017 | $41.01M | +73.1% |
| 2016 | $23.69M | - |